MolNFT v1 · #26465 · protein
Crystal structure of ipmdh from sulfolobus tokodaii
1WPW · 3-isopropylmalate dehydrogenase: “Crystal structure of ipmdh from sulfolobus tokodaii”. X-ray diffraction, 1 ligand (MG), 7 pockets (best druggability 0.74). MolNFT v1 #26465 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 1WPW
- Type
- protein
- Length
- 672 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 3-isopropylmalate dehydrogenase
- EC
- 1.1.1.85
- UniProt
- P50455
- Ligands
- MG
- Pockets
- 7 · best druggability 0.74
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | 3-isopropylmalate dehydrogenase (EC 1.1.1.85) | protein | 336 | 45% helix, 21% strand | P50455 |
Ligands and binding sites
- MG · Magnesium ion · metal · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 236 | 0.74 | 0.89 | 35 | empty |
| 2 | 223 | 0.74 | 0.89 | 36 | empty |
| 3 | 472 | 0.64 | 0.78 | 40 | MG |
| 4 | 464 | 0.64 | 0.78 | 37 | MG |
| 5 | 55 | 0.35 | 0.78 | 11 | empty |
Interfaces
1 interface between chains.
- A–B · 1852 Ų buried · 26 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P50455
- Elsewhere: RCSB PDB 1WPW · PDBe 1WPW · UniProt P50455
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.